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Abstract
Background: As a result of improvements in diagnostic accuracy, the primary source of the
tumour is identified in more than 99% of cases presenting with a malignancy. Whilst the axial
skeleton is a common site of metastases, the sternum is rarely affected, especially by isolated
metastases.
Case presentation: We report a case of a 68 year old male who was referred to the surgical
outpatient clinic with a six month history of sternal pain. The patient was known to have essential
thrombocythaemia, which had recently transformed into acute myeloid leukaemia but a sternal
biospy showed mucinous adenocarcinoma. He had not localising symptoms and full evaluation failed
to localise the primary tumour.
Conclusion: Solitary sternal metastases are rare and when found an underlying neoplasm is usually
identified allowing targeted treatment. If however, there is no symptomatic tumour, the metastasis
should simply be treated symptomatically.
Background
As a result of improvements in radiological imaging
including cross-sectional and radiopharmaceutical stud-
ies, together with refinements in histological assessment
of biopsy specimens such as the use of immunostaining,
the primary site of a malignancy is usually identified and
thus cancer of unknown origin now has an incidence of
only 0.5–0.9% amongst all patients presenting with a
malignancy [1].
Bone is the commonest site for secondary spread of can-
cer, with 80% of metastases arising from breast, lung and
prostatic primary tumours [2]. The metastases are pre-
dominantly located in the axial skeleton within the spine,
pelvis and ribs. Sternal metastases are rare; no series has
been published recording the incidence.
Case presentation
A 68 year old male was referred to the surgical outpatient
clinic with a six month history of sternal pain. The pain
was an intense, continuous burning pain that disrupted
his sleep. The patient was known to have essential throm-
bocythaemia, which had recently transformed into acute
myeloid leukaemia. This had been confirmed by a previ-
ous marrow biopsy taken from the iliac crest just before
the onset of his sternal pain.
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The patient had lost two stones in weight despite no loss
of appetite. There had been no change in his bowel habit.
He reported a single episode of rectal bleeding two
months prior to his presentation that had been attributed
to aspirin therapy. The patient admitted to smoking ten
cigarettes a day but denied any respiratory symptoms.
On examination he was acutely tender in the mid-sternal
region, but no mass was palpable. No breast or axillary
masses were detected. Examination of the abdomen
revealed three centimetres of hepatomegaly, a normal
spleen but no other masses. Prostatic and rectal examina-
tions were normal. Flexible sigmoidoscopy was also nor-
mal. A full blood count was consistent with his
leukaemia. His renal function, liver function tests and
prostate specific antigen tests were within normal limits.
The patient underwent a magnetic resonance imaging
(MRI) scan which showed abnormal marrow signal in the
body of the sternum with expansion and loss of the ante-
rior and posterior cortical margins (Figure 1). A computer-
ised tomographic (CT) guided biopsy of the sternum was
performed, histological examination of which identified a
mucin-secreting adenocarcinoma. The patient subse-
quently had a full body CT scan and a bone scan. The CT
scan was normal, specifically showing no abnormality in
the thorax or alimentary tract. The bone scan confirmed a
solitary metastatic deposit in the sternum. The patient was
then referred to an oncologist for radiotherapy.
Discussion
Cancer of an unknown primary site has a median survival
of 9–12 months from initial detection [1]. The aim of clin-
ical investigations in these cases is to obtain a biopsy of
the metastatic lesion and to try to identify the source of
the primary tumour.
Abeloff and colleagues [3] recommend the following
series of tests: full history and examination, routine blood
tests including tumour markers, chest radiograph and CT
scan of the abdomen and pelvis. For those patients with
no obvious primary tumour, the treatment will depend on
the presenting metastasis. For a patient with a single bony
metastasis, local treatment in the form of radiotherapy
combined with analgesia is used to combat pain. If a
patient has multiple metastases from an adenocarcinoma,
some clinicians would consider giving systemic chemo-
therapy.
Bone is the commonest site for metastatic spread, espe-
cially in tumours involving the breast, lung, prostate, kid-
ney and thyroid gland. The axial skeleton is usually
affected, believed to be due to the vertebral-venous
plexus, and the slow blood flow in the axial skeleton.
Bony metastases present with pain and local tenderness,
problems with mobility and pathological fractures.
Although metastases to the vertebrae and ribs are com-
mon, sternal metastases are rare. Whilst there are several
case reports of metastases from known primary tumours
in the English language literature, there are only four
series reported in the literature in the last sixty years [2,4-
6]. However, these papers do not report an incidence as
there is insufficient histological material to enable reliable
conclusions to be made. Toussiet et al. [4] reported ten
patients whose first presentation of a malignancy was a
sternal deposit. Eight of the ten cases were haematological
malignancies, and the other two were of renal and bron-
chial origin.
Mucinous adenocarcinoma such as described in this case
may arise in the breast, lung, prostate, pancreas and
bowel. Despite thorough investigation, we were unable to
detect a source of the primary mucinous adenocarcinoma.
This case demonstrates that bony pain in patients with a
haematological malignancy may be due to a second pri-
mary carcinoma. Sternal pain has many causes including
neuropathic, musculo-skeletal and infective. Although
metastasis is a rare cause of sternal pain, it should not be
overlooked.
MRI scan demonstrating sternal metastasis with loss of mar- row signal and abnormal cortical margins Figure 1
MRI scan demonstrating sternal metastasis with loss of mar-
row signal and abnormal cortical margins. The white arrow 
identifies the metastasis within the body of the sternum.Publish with BioMed Central    and   every 
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We question how aggressively a clinician should search
for the primary site. With a life expectancy of less than a
year, it may be kinder to the patient to restrict investiga-
tions to blood tests, a chest radiograph and a CT abdomen
and pelvis. Further tests such as endoscopy, bone scans
and barium enemas are uncomfortable for the patient and
it may be argued that they should be avoided.
Conclusion
Despite advances in medical imaging, there remain rare
cases in which no primary can be identified for isolated
metastases. In the case of bone metastases from adenocar-
cinoma, it may be appropriate to treat the metastasis
symptomatically and not be too concerned with hunting
the primary lesion.
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